Unfortunately, that's not always the case, between 20-40% of those who've had surgery, have biochemical recurrence. The risk of BCR is dependant on my factors, including the aggressiveness of the cancer, but even those with low/intermediate grade cancer, have about a 20% chance of recurrence. I believe the recurrence rates are similar for other treatments.
Initially, I had a very similar diagnosis to yours. Gleason 6, T2a, PSA 5.6. Statistically, I had a 50% chance of not needing further treatment in the following ten years. I liked those odds and took a chance.
Unfortunately, during the following two years, they discovered disease progression and I opted for surgery. Three and a half years later, its been successful, but I still have a high chance of BCR.
Although my active surveillance ultimately failed, if I were in your position, I'd still give it a go.
My reasoning for this is you've roughly got a one in two chance of not needing further treatment in the next ten years, and no risk of treatment side effects. Where as if you opted for surgery you've got a 1 in 5 chance of recurrence and a high risk of side effects.
The beauty of active surveillance is you can change your mind and if things go awry opt for a radical treatment. You say that you find it difficult going on active surveillance in case the cancer grew. I appreciate that, I had the same concern, but I find the checks for BCR just as worrying.
My thoughts are why try and fix something that might never need fixing.
My only concerns about active surveillance is it being largely based on biopsy results which can be inaccurate. I believe that my initial biopsy missed the more aggressive cancer cells.
It must also be ACTIVE surveillance. You must ensure that your follow up PSA checks, MRI scans and possible biopsies are done in a timely fashion. Mine weren't.
I hope that your appointment goes well today and whatever treatment path is planned, it works for you.
Edited by member 24 Aug 2026 at 10:20
| Reason: Additional text